Cargando…

Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial

BACKGROUND: Seeking consent rapidly in acute stroke trials is crucial as interventions are time sensitive. We explored the association between consent pathways and time to enrollment in the TICH-2 (Tranexamic Acid in Intracerebral Haemorrhage-2) randomized controlled trial. METHODS: Consent was prov...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Zhe Kang, Appleton, Jason P., Scutt, Polly, Roberts, Ian, Al-Shahi Salman, Rustam, England, Timothy J., Werring, David J., Robinson, Thompson, Krishnan, Kailash, Dineen, Robert A., Laska, Ann Charlotte, Lyrer, Philippe A., Egea-Guerrero, Juan Jose, Karlinski, Michal, Christensen, Hanne, Roffe, Christine, Bereczki, Daniel, Ozturk, Serefnur, Thanabalan, Jegan, Collins, Ronan, Beridze, Maia, Ciccone, Alfonso, Duley, Lelia, Shone, Angela, Bath, Philip M., Sprigg, Nikola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612544/
https://www.ncbi.nlm.nih.gov/pubmed/34847710
http://dx.doi.org/10.1161/STROKEAHA.121.035191
_version_ 1783605380688904192
author Law, Zhe Kang
Appleton, Jason P.
Scutt, Polly
Roberts, Ian
Al-Shahi Salman, Rustam
England, Timothy J.
Werring, David J.
Robinson, Thompson
Krishnan, Kailash
Dineen, Robert A.
Laska, Ann Charlotte
Lyrer, Philippe A.
Egea-Guerrero, Juan Jose
Karlinski, Michal
Christensen, Hanne
Roffe, Christine
Bereczki, Daniel
Ozturk, Serefnur
Thanabalan, Jegan
Collins, Ronan
Beridze, Maia
Ciccone, Alfonso
Duley, Lelia
Shone, Angela
Bath, Philip M.
Sprigg, Nikola
author_facet Law, Zhe Kang
Appleton, Jason P.
Scutt, Polly
Roberts, Ian
Al-Shahi Salman, Rustam
England, Timothy J.
Werring, David J.
Robinson, Thompson
Krishnan, Kailash
Dineen, Robert A.
Laska, Ann Charlotte
Lyrer, Philippe A.
Egea-Guerrero, Juan Jose
Karlinski, Michal
Christensen, Hanne
Roffe, Christine
Bereczki, Daniel
Ozturk, Serefnur
Thanabalan, Jegan
Collins, Ronan
Beridze, Maia
Ciccone, Alfonso
Duley, Lelia
Shone, Angela
Bath, Philip M.
Sprigg, Nikola
author_sort Law, Zhe Kang
collection PubMed
description BACKGROUND: Seeking consent rapidly in acute stroke trials is crucial as interventions are time sensitive. We explored the association between consent pathways and time to enrollment in the TICH-2 (Tranexamic Acid in Intracerebral Haemorrhage-2) randomized controlled trial. METHODS: Consent was provided by patients or by a relative or an independent doctor in incapacitated patients, using a 1-stage (full written consent) or 2-stage (initial brief consent followed by full written consent post-randomization) approach. The computed tomography-to-randomization time according to consent pathways was compared using the Kruskal-Wallis test. Multivariable logistic regression was performed to identify variables associated with onset-to-randomization time of ≤3 hours. RESULTS: Of 2325 patients, 817 (35%) gave self-consent using 1-stage (557; 68%) or 2-stage consent (260; 32%). For 1507 (65%), consent was provided by a relative (1 stage, 996 [66%]; 2 stage, 323 [21%]) or a doctor (all 2-stage, 188 [12%]). One patient did not record prerandomization consent, with written consent obtained subsequently. The median (interquartile range) computed tomography-to-randomization time was 55 (38–93) minutes for doctor consent, 55 (37–95) minutes for 2-stage patient, 69 (43–110) minutes for 2-stage relative, 75 (48–124) minutes for 1-stage patient, and 90 (56–155) minutes for 1-stage relative consents (P<0.001). Two-stage consent was associated with onset-to-randomization time of ≤3 hours compared with 1-stage consent (adjusted odds ratio, 1.9 [95% CI, 1.5–2.4]). Doctor consent increased the odds (adjusted odds ratio, 2.3 [1.5–3.5]) while relative consent reduced the odds of randomization ≤3 hours (adjusted odds ratio, 0.10 [0.03–0.34]) compared with patient consent. Only 2 of 771 patients (0.3%) in the 2-stage pathways withdrew consent when full consent was sought later. Two-stage consent process did not result in higher withdrawal rates or loss to follow-up. CONCLUSIONS: The use of initial brief consent was associated with shorter times to enrollment, while maintaining good participant retention. Seeking written consent from relatives was associated with significant delays. REGISTRATION: URL: https://www.isrctn.com; Unique identifier: ISRCTN93732214.
format Online
Article
Text
id pubmed-7612544
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-76125442022-04-01 Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial Law, Zhe Kang Appleton, Jason P. Scutt, Polly Roberts, Ian Al-Shahi Salman, Rustam England, Timothy J. Werring, David J. Robinson, Thompson Krishnan, Kailash Dineen, Robert A. Laska, Ann Charlotte Lyrer, Philippe A. Egea-Guerrero, Juan Jose Karlinski, Michal Christensen, Hanne Roffe, Christine Bereczki, Daniel Ozturk, Serefnur Thanabalan, Jegan Collins, Ronan Beridze, Maia Ciccone, Alfonso Duley, Lelia Shone, Angela Bath, Philip M. Sprigg, Nikola Stroke Clinical Trials BACKGROUND: Seeking consent rapidly in acute stroke trials is crucial as interventions are time sensitive. We explored the association between consent pathways and time to enrollment in the TICH-2 (Tranexamic Acid in Intracerebral Haemorrhage-2) randomized controlled trial. METHODS: Consent was provided by patients or by a relative or an independent doctor in incapacitated patients, using a 1-stage (full written consent) or 2-stage (initial brief consent followed by full written consent post-randomization) approach. The computed tomography-to-randomization time according to consent pathways was compared using the Kruskal-Wallis test. Multivariable logistic regression was performed to identify variables associated with onset-to-randomization time of ≤3 hours. RESULTS: Of 2325 patients, 817 (35%) gave self-consent using 1-stage (557; 68%) or 2-stage consent (260; 32%). For 1507 (65%), consent was provided by a relative (1 stage, 996 [66%]; 2 stage, 323 [21%]) or a doctor (all 2-stage, 188 [12%]). One patient did not record prerandomization consent, with written consent obtained subsequently. The median (interquartile range) computed tomography-to-randomization time was 55 (38–93) minutes for doctor consent, 55 (37–95) minutes for 2-stage patient, 69 (43–110) minutes for 2-stage relative, 75 (48–124) minutes for 1-stage patient, and 90 (56–155) minutes for 1-stage relative consents (P<0.001). Two-stage consent was associated with onset-to-randomization time of ≤3 hours compared with 1-stage consent (adjusted odds ratio, 1.9 [95% CI, 1.5–2.4]). Doctor consent increased the odds (adjusted odds ratio, 2.3 [1.5–3.5]) while relative consent reduced the odds of randomization ≤3 hours (adjusted odds ratio, 0.10 [0.03–0.34]) compared with patient consent. Only 2 of 771 patients (0.3%) in the 2-stage pathways withdrew consent when full consent was sought later. Two-stage consent process did not result in higher withdrawal rates or loss to follow-up. CONCLUSIONS: The use of initial brief consent was associated with shorter times to enrollment, while maintaining good participant retention. Seeking written consent from relatives was associated with significant delays. REGISTRATION: URL: https://www.isrctn.com; Unique identifier: ISRCTN93732214. Lippincott Williams & Wilkins 2021-12-01 2022-04 /pmc/articles/PMC7612544/ /pubmed/34847710 http://dx.doi.org/10.1161/STROKEAHA.121.035191 Text en © 2021 The Authors. https://creativecommons.org/licenses/by/4.0/Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
spellingShingle Clinical Trials
Law, Zhe Kang
Appleton, Jason P.
Scutt, Polly
Roberts, Ian
Al-Shahi Salman, Rustam
England, Timothy J.
Werring, David J.
Robinson, Thompson
Krishnan, Kailash
Dineen, Robert A.
Laska, Ann Charlotte
Lyrer, Philippe A.
Egea-Guerrero, Juan Jose
Karlinski, Michal
Christensen, Hanne
Roffe, Christine
Bereczki, Daniel
Ozturk, Serefnur
Thanabalan, Jegan
Collins, Ronan
Beridze, Maia
Ciccone, Alfonso
Duley, Lelia
Shone, Angela
Bath, Philip M.
Sprigg, Nikola
Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial
title Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial
title_full Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial
title_fullStr Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial
title_full_unstemmed Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial
title_short Brief Consent Methods Enable Rapid Enrollment in Acute Stroke Trial: Results From the TICH-2 Randomized Controlled Trial
title_sort brief consent methods enable rapid enrollment in acute stroke trial: results from the tich-2 randomized controlled trial
topic Clinical Trials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7612544/
https://www.ncbi.nlm.nih.gov/pubmed/34847710
http://dx.doi.org/10.1161/STROKEAHA.121.035191
work_keys_str_mv AT lawzhekang briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT appletonjasonp briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT scuttpolly briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT robertsian briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT alshahisalmanrustam briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT englandtimothyj briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT werringdavidj briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT robinsonthompson briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT krishnankailash briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT dineenroberta briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT laskaanncharlotte briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT lyrerphilippea briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT egeaguerrerojuanjose briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT karlinskimichal briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT christensenhanne briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT roffechristine briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT bereczkidaniel briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT ozturkserefnur briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT thanabalanjegan briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT collinsronan briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT beridzemaia briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT cicconealfonso briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT duleylelia briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT shoneangela briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT bathphilipm briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial
AT spriggnikola briefconsentmethodsenablerapidenrollmentinacutestroketrialresultsfromthetich2randomizedcontrolledtrial